Are influences during pregnancy associated with wheezing phenotypes during the first decade of life?

Ramesh J Kurukulaaratchy1, Linda Waterhouse, Sharon M Matthews

  • 1David Hide Asthma & Allergy Research Centre, St Mary's Hospital, Newport, Isle of Wight, United Kingdom.

Insights

Maternal exposures during pregnancy, like environmental tobacco smoke, are linked to childhood wheezing phenotypes. Cat ownership may reduce the risk of persistent wheeze in children.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Epidemiology

Background:

  • Asthma's origins are increasingly linked to early life factors.
  • Understanding prenatal influences is crucial for preventing childhood respiratory conditions.

Purpose of the Study:

  • To investigate the association between maternal exposures during pregnancy and the development of childhood wheezing phenotypes.
  • To identify specific prenatal risk and protective factors for different wheeze patterns.

Main Methods:

  • A UK birth cohort study followed 1456 children to age 10.
  • Maternal pregnancy exposures were extracted from maternity records.
  • Wheezing phenotypes were defined based on symptoms recorded at ages 1, 2, 4, and 10 years.

Main Results:

  • Environmental tobacco smoke exposure in pregnancy increased the risk of early-onset persistent wheeze (OR=2.44) and early transient wheeze (OR=1.58).
  • Maternal asthma was associated with increased risk of early-onset persistent wheeze (OR=3.57).
  • Cat ownership during pregnancy was associated with a reduced risk of early-onset persistent wheeze (OR=0.30).
  • Male gender and low birthweight were associated with early transient wheeze.
  • No significant associations were found between prenatal environmental factors and late-onset persistent wheeze.

Conclusions:

  • Maternal exposures during pregnancy, alongside genetic factors, are significantly associated with childhood wheezing phenotypes.
  • Prenatal environmental tobacco smoke and maternal asthma are risk factors, while cat ownership may be protective for early-onset wheeze.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...